Bellerophon Therapeutics Company
Bellerophon focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary diseases.
Investors
Headquarters:
Warren, New Jersey, United States
Funding Status:
IPO
Employee Number:
11-50
Estimated Revenue:
$1M to $10M
Investment Stage:
N/A
Number Of Exists:
N/A
Technology:
Cancer
Investor Type:
N/A
Founded Date:
2009
Industry:
PharmTech